drugset / Trial / NCT07422389

BRM421 Ophthalmic Solution in Patients With Limbal Stem Cell Deficiency

NCT07422389 ↗

Summary

The goal of this program is to provide patients with Limbal Stem Cell Deficiency access to the BRM421 eye drops. Participants will: * Use BRM421 two times a day for at least 12 weeks * Visit the clinic monthly for checkups and tests

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject BRM421 Unknown 0.06 % Topical